GLS enhances glycolysis in esophageal squamous cell carcinoma (ESCC) by interacting with PDK1, so co-targeting GLS and PDK1 may be a novel therapeutic approach for ESCC patients [151]. This evidence concerns the gene PDK1 and esophageal squamous cell carcinoma.